CARMAT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.15 EUR | -2.63% |
|
-17.21% | -52.99% |
| 25/03 | Carmat: final agreement with creditors | CF |
| 25/03 | Carmat Secures Two-year Extensions for Bank Loans | MT |
Chart calendar CARMAT
1805f20fccbfdaa413351bd766587c8.vgNfP_jsXEgMyMZzzi4ZK2UaTi7MMDGDvG0nvvfd4KA.znsRb5KOJj8_q4skqVpYHB95F0m9aVra8lke3ZCTpZDSVi5asY8PBW_lpQ~5c31f12967b8d65c465318eaead803af
Upcoming events on CARMAT
Past events on CARMAT
| 24/04/2024 10:30 am | Q4 2023 Earnings Release |
| 10/04/2024 | International Society of Heart and Lung Transplantation Meeting |
| 18/01/2024 12:30 am | Business Update Call |
| 05/01/2024 | Extraordinary Shareholders Meeting |
| 22/11/2023 | EuroLand Corporate Investor Forum |
| 02/11/2023 | EACTS Mechanical Circulatory Support Summit |
| 18/10/2023 | Cardiac Surgery National Conference |
| 04/10/2023 | Portzamparc BNP Paribas Biotech & Health Forum |
| 04/10/2023 | European Association for Cardio Thoracic Surgery Meeting |
| 25/09/2023 11:30 pm | Q2 2023 Earnings Call |
| 25/09/2023 10:30 am | Q2 2023 Earnings Release |
| 21/09/2023 | JFIC CAT Congress |
| 03/09/2023 | European Mechanical Circulatory Support Summit |
| 11/05/2023 | Annual General Meeting |
| 23/02/2023 11:30 am | FY 2022 Earnings Release |
| 24/01/2023 12:30 am | Business Update Call |
| 17/11/2022 | EACTS Mechanical Circulatory Support Summit |
| 17/10/2022 | Fall European Mid-Cap Conference |
| 05/10/2022 | EACTS Meeting |
| 04/10/2022 | Portzamparc BNP Paribas Biotech & Health Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,24 - | 0,70 0,23 202.15% | 0,00 0,32 - | 2,20 3,96 -44.46% | 0,30 3,38 -91.12% | 2,80 8,10 -65.45% |
|
EBITDA Million EUR | Released Forecast Spread | -41,1 -36,0 -14.24% | -41,2 -46,5 11.29% | -27,6 -41,1 32.86% | -51,1 -46,0 -11% | -50,2 -42,5 -18.17% | 0,00 -43,0 - |
|
EBIT Million EUR | Released Forecast Spread | -42,8 -37,5 -14.13% | -42,4 -44,8 5.27% | -36,4 -40,2 9.56% | -52,4 -58,2 9.98% | -51,9 -47,4 -9.42% | -52,5 -51,5 -1.85% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -43,7 -38,0 -15.18% | -44,2 -49,5 10.69% | -38,9 -43,9 11.45% | -63,7 -55,6 -14.68% | -55,8 -55,4 -0.64% | 0,00 -57,6 - |
|
Net income Million EUR | Released Forecast Spread | -41,7 -38,3 -8.94% | -42,6 -44,6 4.42% | -37,0 -39,5 6.31% | -61,9 -53,4 -15.97% | -53,7 -43,8 -22.56% | -53,9 -49,3 -9.4% |
|
EPS EUR | Released Forecast Spread | -4,50 -3,97 -13.35% | -3,38 -4,09 17.41% | -2,85 -3,18 10.41% | -3,97 -3,54 -12% | -2,37 -2,40 1.14% | 0,00 -2,07 - |
| Announcement Date | 13/02/19 | 12/02/20 | 10/02/21 | 16/02/22 | 23/02/23 | 24/04/24 |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,43 - | 0,00 1,08 - | 0,00 1,00 - | 0,00 | 1,10 2,00 -45% | 1,10 2,00 -45% | 2,20 4,03 -45.41% | 0,06 0,00 - | 0,06 0,00 - | 0,00 0,05 - | 0,00 0,00 - | 2,10 | 0,30 1,27 -76.38% | 1,50 | 2,00 | 0,60 | 5,50 | 8,00 | 5,05 | 5,49 | 12,6 | 21,9 | 35,4 | |||
|
EBIT Million EUR | Released Forecast Spread | -20,6 -21,8 5.68% | -15,8 -20,6 23.45% | -12,8 -9,37 -36.29% | -25,5 | -13,4 -14,0 4.22% | -13,4 -14,0 4.22% | -26,9 -29,6 9.18% | -12,5 -14,9 15.67% | -12,5 -14,9 15.67% | -25,1 -25,7 2.37% | -16,1 | -11,5 | -26,8 -25,4 -5.43% | -11,9 | -11,4 | -12,6 | -10,1 | -33,4 | -26,1 | -26,0 | -23,5 | -18,9 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -21,6 -23,1 6.25% | -17,3 -21,9 21.04% | -13,5 -10,00 -35.17% | -18,4 -14,6 -26.05% | -18,4 -14,6 -26.05% | -36,7 -31,1 -18.12% | -13,5 -15,5 13.07% | -13,5 -15,5 13.07% | -26,9 -27,4 1.93% | -17,0 | -12,4 | -27,6 | -12,8 | -12,3 | -13,5 | -11,0 | -35,5 | -28,1 | -28,2 | -25,7 | -21,2 | |||||
|
Net income Million EUR | Released Forecast Spread | -20,8 -22,5 7.35% | -16,2 -20,8 22.15% | -13,2 -10,00 -31.87% | -26,4 | -17,8 -14,6 -21.8% | -17,8 -14,6 -21.8% | -35,5 -30,4 -16.93% | -13,0 -15,5 16.1% | -13,0 -15,5 16.1% | -26,0 -26,8 2.99% | -17,0 | -12,4 | -12,8 | -12,3 | -26,7 | -13,5 | -11,0 | -32,0 | -24,7 | -24,8 | -23,8 | -19,3 | ||||
|
EPS EUR | Released Forecast Spread | -1,73 | -1,54 | -0,65 | -1,71 -1,34 -27.83% | -1,14 -0,95 -20% | -1,14 -0,95 -20% | -2,26 -1,84 -22.67% | -1,01 | -0,94 | -1,37 | -0,86 | -0,63 | -0,57 | -0,54 | -0,59 | -0,44 | -1,23 | -0,30 | -0,23 | -0,82 | -0,15 | -0,73 | -0,66 | -0,48 | ||
| Announcement Date | 09/09/20 | 10/02/21 | 15/09/21 | 15/09/21 | 15/09/22 | 16/02/22 | 16/02/22 | 15/09/22 | 15/09/22 | 15/09/22 | 23/02/23 | - | 23/02/23 | - | - | 25/09/23 | - | - | - | - | - | - | - | - | - | - |
| 29/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 01/05/2024 11:30 am | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 02/05/2024 01:35 am | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | AXONICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 03:30 pm | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 06/05/2024 | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
Past sector events for CARMAT
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCAR Stock
- Calendar CARMAT
